Shanghai Kehua Bio-Engineering, an IVD company, signed an MOU to acquire Technogenetics S.r.l., an Italian maker of diagnostic tests, from its parent, Bouty Healthcare S.P.A. Kehua will also buy all the diagnostic assets of Altergon Italia. Technogenetics offers clinical diagnostic tests for autoimmune and infectious diseases tests, using the IDS-iSYS chemiluminescence machine. Kehua, which has until October 15 to complete the deal, will first perform due diligence and then negotiate a final agreement.
Help employers find you! Check out all the jobs and post your resume.